{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:43:09Z","timestamp":1794915789848,"version":"4.9.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["Liu investigatorship"],"award-info":[{"award-number":["Liu investigatorship"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI142756"],"award-info":[{"award-number":["U01 AI142756"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute","doi-asserted-by":"publisher","award":["RM1 HG009490"],"award-info":[{"award-number":["RM1 HG009490"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM118062"],"award-info":[{"award-number":["R35 GM118062"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Zellweger spectrum disorder (ZSD) is caused by biallelic loss-of-function variants in\n                    <jats:italic>PEX<\/jats:italic>\n                    genes required for peroxisome biogenesis, which is critical for normal cellular metabolism and signalling. The\n                    <jats:italic>PEX1<\/jats:italic>\n                    -p.G843D (c.2528G&gt;A) allele, present in approximately 30% of individuals with ZSD, frequently results in chronic liver disease that can progress to cirrhosis, hepatocellular carcinoma and degraded neurological health. Here we report the development and application of an adenine base editing strategy to correct an established homozygous\n                    <jats:italic>Pex1<\/jats:italic>\n                    -p.G844D ZSD mouse model that manifests liver pathologies and metabolic dysfunction found in patients. Through intravenous delivery of AAV9 encoding ABE8e-V106W into both neonatal and 4-week-old mice, we achieved up to 60% pathogenic allele correction in the bulk liver. By restoring peroxisome function, base editing eliminated bulk accumulation of very long-chain and branched-chain fatty acids, and toxic C27-bile acid intermediates. Increased levels of phytanic acid, a branched-chain fatty acid that becomes harmful when accumulated, were normalized in blood, liver and brain tissue. Treatment of homozygous\n                    <jats:italic>Pex1<\/jats:italic>\n                    -p.G844D mice resulted in the progressive, dose-dependent normalization of liver transcriptomes and histopathology, accompanied by gains in body weight. Non-viral lipid nanoparticle delivery of ABE8e-V106W mRNA to 4-week-old mice also yielded correction of the\n                    <jats:italic>Pex1<\/jats:italic>\n                    -p.G844D allele in 27% of bulk liver cells. In patient-derived fibroblasts, base editing corrected &gt;80% of\n                    <jats:italic>PEX1<\/jats:italic>\n                    -p.G843D alleles and restored peroxisome homeostasis. Genome-wide experimental and computational off-target analyses found minimal off-target editing in the mouse or human genome. Collectively, these findings suggest that liver base editing over a range of ages may benefit individuals with ZSD and provides a foundation for developing precision gene correction treatments that address the root cause of a wide range of peroxisomal disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41551-026-01651-5","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:02:27Z","timestamp":1776157347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vivo base editing rescues liver pathophysiology and peroxisome dysfunction in a mouse model of Zellweger spectrum disorder"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2917-2060","authenticated-orcid":false,"given":"Xin D.","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Presa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordyn E.","family":"Duby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alexandre","family":"Piec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4034-2788","authenticated-orcid":false,"given":"Alvin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samagya","family":"Banskota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9826-5976","authenticated-orcid":false,"given":"Allen Yujie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erminia","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8061-7953","authenticated-orcid":false,"given":"Jonathan M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford H.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lecordier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9147-1902","authenticated-orcid":false,"given":"Ann B.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-1567","authenticated-orcid":false,"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-9012","authenticated-orcid":false,"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir R.","family":"Zuberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-9282","authenticated-orcid":false,"given":"Joseph G.","family":"Hacia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2502-1900","authenticated-orcid":false,"given":"Cathleen M.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9943-7557","authenticated-orcid":false,"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-94-007-6889-5_2","volume":"69","author":"RJA Wanders","year":"2013","unstructured":"Wanders, R. J. A. Peroxisomes and their key role in cellular signaling and metabolism. Subcell. Biochem. 69, 23\u201344 (2013).","journal-title":"Subcell. Biochem."},{"key":"1651_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/ars.2018.7515","volume":"30","author":"M Fransen","year":"2019","unstructured":"Fransen, M. & Lismont, C. Redox signaling from and to peroxisomes: progress, challenges, and prospects. Antioxid. Redox Signal. 30, 95\u2013112 (2019).","journal-title":"Antioxid. Redox Signal."},{"key":"1651_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ceb.2016.02.017","volume":"39","author":"DN Tripathi","year":"2016","unstructured":"Tripathi, D. N. & Walker, C. L. The peroxisome as a cell signaling organelle. Curr. Opin. Cell Biol. 39, 109\u2013112 (2016).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1651_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.tcb.2021.02.005","volume":"31","author":"A He","year":"2021","unstructured":"He, A., Dean, J. M. & Lodhi, I. J. Peroxisomes as cellular adaptors to metabolic and environmental stress. Trends Cell Biol. 31, 656\u2013670 (2021).","journal-title":"Trends Cell Biol."},{"key":"1651_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-60204-8_1","volume":"1299","author":"K Okumoto","year":"2021","unstructured":"Okumoto, K., Tamura, S., Honsho, M. & Fujiki, Y. Peroxisome biology: experimental models, peroxisomal disorders and neurological diseases. Adv. Exp. Med. Biol. 1299, 3\u201317 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1152\/physrev.00051.2021","volume":"103","author":"RJA Wanders","year":"2023","unstructured":"Wanders, R. J. A., Baes, M., Ribeiro, D., Ferdinandusse, S. & Waterham, H. R. The physiological functions of human peroxisomes. Physiol. Rev. 103, 957\u20131024 (2023).","journal-title":"Physiol. Rev."},{"key":"1651_CR7","doi-asserted-by":"publisher","first-page":"119330","DOI":"10.1016\/j.bbamcr.2022.119330","volume":"1869","author":"Y Fujiki","year":"2022","unstructured":"Fujiki, Y., Okumoto, K., Honsho, M. & Abe, Y. Molecular insights into peroxisome homeostasis and peroxisome biogenesis disorders. Biochim. Biophys. Acta Mol. Cell Res. 1869, 119330 (2022).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1651_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcell.2015.00083","volume":"3","author":"RJA Wanders","year":"2016","unstructured":"Wanders, R. J. A., Waterham, H. R. & Ferdinandusse, S. Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum. Front. Cell Dev. Biol. 3, 83 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"1651_CR9","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.molcel.2022.05.028","volume":"82","author":"E Zalckvar","year":"2022","unstructured":"Zalckvar, E. & Schuldiner, M. Beyond rare disorders: a new era for peroxisomal pathophysiology. Mol. Cell 82, 2228\u20132235 (2022).","journal-title":"Mol. Cell"},{"key":"1651_CR10","unstructured":"Steinberg, S. J., Raymond, G. V., Braverman, N. E. & Moser, A. B. in GeneReviews (eds Adam, M. P. et al.) (Univ. Washington, 2020)."},{"key":"1651_CR11","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/s41436-019-0468-3","volume":"21","author":"E Vasiljevic","year":"2019","unstructured":"Vasiljevic, E. et al. Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools. Genet. Med. 21, 1969\u20131976 (2019).","journal-title":"Genet. Med."},{"key":"1651_CR12","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/cells11132067","volume":"11","author":"RM Judy","year":"2022","unstructured":"Judy, R. M., Sheedy, C. J. & Gardner, B. M. Insights into the structure and function of the Pex1\/Pex6 AAA-ATPase in peroxisome homeostasis. Cells 11, 2067 (2022).","journal-title":"Cells"},{"key":"1651_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41640-9","volume":"14","author":"M R\u00fcttermann","year":"2023","unstructured":"R\u00fcttermann, M. et al. Structure of the peroxisomal Pex1\/Pex6 ATPase complex bound to a substrate. Nat. Commun. 14, 5942 (2023).","journal-title":"Nat. Commun."},{"key":"1651_CR14","doi-asserted-by":"publisher","first-page":"167896","DOI":"10.1016\/j.jmb.2022.167896","volume":"435","author":"AG Pedrosa","year":"2023","unstructured":"Pedrosa, A. G. et al. The extraction mechanism of monoubiquitinated PEX5 from the peroxisomal membrane. J. Mol. Biol. 435, 167896 (2023).","journal-title":"J. Mol. Biol."},{"key":"1651_CR15","doi-asserted-by":"crossref","unstructured":"Karuntu, J. S., Klouwer, F. C. C., Engelen, M. & Boon, C. J. F. Systematic study of ophthalmological findings in 10 patients with PEX1-mediated Zellweger spectrum disorder. Ophthalmic Genet. 45, 351\u2013362 (2024).","DOI":"10.1080\/13816810.2024.2330389"},{"key":"1651_CR16","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jimd.12132","volume":"42","author":"K Berendse","year":"2019","unstructured":"Berendse, K. et al. Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder. J. Inherit. Metab. Dis. 42, 955\u2013965 (2019).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1651_CR17","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3390\/cells11121891","volume":"11","author":"M Bose","year":"2022","unstructured":"Bose, M. et al. Characterization of severity in Zellweger spectrum disorder by clinical findings: a scoping review, meta-analysis and medical chart review. Cells 11, 1891 (2022).","journal-title":"Cells"},{"key":"1651_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.ophtha.2023.07.026","volume":"130","author":"C Yergeau","year":"2023","unstructured":"Yergeau, C. et al. Zellweger spectrum disorder ophthalmic findings from a new natural history study cohort and scoping literature review. Ophthalmology 130, 1313\u20131326 (2023).","journal-title":"Ophthalmology"},{"key":"1651_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ddrr.1113","volume":"17","author":"NE Braverman","year":"2013","unstructured":"Braverman, N. E., D\u2019Agostino, M. D. & MacLean, G. E. Peroxisome biogenesis disorders: biological, clinical and pathophysiological perspectives. Dev. Disabil. Res. Rev. 17, 187\u2013196 (2013).","journal-title":"Dev. Disabil. Res. Rev."},{"key":"1651_CR20","doi-asserted-by":"crossref","unstructured":"Rosewich, H., Ohlenbusch, A. & G\u00e4rtner, J. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations. J. Med. Genet. 42, e58\u2013e58 (2005).","DOI":"10.1136\/jmg.2005.033324"},{"key":"1651_CR21","doi-asserted-by":"publisher","first-page":"100516","DOI":"10.1016\/j.jlr.2024.100516","volume":"65","author":"B Morales-Romero","year":"2024","unstructured":"Morales-Romero, B. et al. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal \u03b2-oxidation disorders. J. Lipid Res. 65, 100516 (2024).","journal-title":"J. Lipid Res."},{"key":"1651_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fcell.2020.00690","volume":"8","author":"YRJ Jaspers","year":"2020","unstructured":"Jaspers, Y. R. J. et al. Comparison of the diagnostic performance of C26:0-lysophosphatidylcholine and very long-chain fatty acids analysis for peroxisomal disorders. Front. Cell Dev. Biol. 8, 690 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1651_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","volume":"117","author":"NE Braverman","year":"2016","unstructured":"Braverman, N. E. et al. Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines. Mol. Genet. Metab. 117, 313\u2013321 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"1651_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jimd.12042","volume":"42","author":"FCC Klouwer","year":"2019","unstructured":"Klouwer, F. C. C. et al. The cholic acid extension study in Zellweger spectrum disorders: results and implications for therapy. J. Inherit. Metab. Dis. 42, 303\u2013312 (2019).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1651_CR25","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1097\/MPG.0000000000001763","volume":"66","author":"FCC Klouwer","year":"2018","unstructured":"Klouwer, F. C. C. et al. Oral cholic acid in Zellweger spectrum disorders. J. Pediatr. Gastroenterol. Nutr. 66, e57 (2018).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"1651_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10545-016-9962-9","volume":"39","author":"K Berendse","year":"2016","unstructured":"Berendse, K. et al. Cholic acid therapy in Zellweger spectrum disorders. J. Inherit. Metab. Dis. 39, 859\u2013868 (2016).","journal-title":"J. Inherit. Metab. Dis."},{"key":"1651_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12098-023-04937-7","volume":"91","author":"J Menon","year":"2024","unstructured":"Menon, J., Shanmugam, N., Vij, M., Rammohan, A. & Rela, M. Liver transplantation for Zellweger syndrome. Indian J. Pediatr. 91, 507\u2013509 (2024).","journal-title":"Indian J. Pediatr."},{"key":"1651_CR28","doi-asserted-by":"publisher","first-page":"e13112","DOI":"10.1111\/petr.13112","volume":"22","author":"T Demaret","year":"2018","unstructured":"Demaret, T. et al. Living-donor liver transplantation for mild Zellweger spectrum disorder: up to 17 years follow-up. Pediatr. Transplant. 22, e13112 (2018).","journal-title":"Pediatr. Transplant."},{"key":"1651_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/01.TP.0000077420.81365.53","volume":"76","author":"EM Sokal","year":"2003","unstructured":"Sokal, E. M. et al. Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76, 735\u2013738 (2003).","journal-title":"Transplantation"},{"key":"1651_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63941","volume":"197","author":"C Gonzalez","year":"2025","unstructured":"Gonzalez, C. et al. Subacute neuropathy post-liver transplantation in Zellweger spectrum disorder: a case report. Am. J. Med. Genet. A 197, e63941 (2025).","journal-title":"Am. J. Med. Genet. A"},{"key":"1651_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson\u2013Gilford progeria syndrome in mice. Nature 589, 608\u2013614 (2021).","journal-title":"Nature"},{"key":"1651_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","volume":"595","author":"GA Newby","year":"2021","unstructured":"Newby, G. A. et al. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature 595, 295\u2013302 (2021).","journal-title":"Nature"},{"key":"1651_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2023.02.027","volume":"186","author":"GE McAuley","year":"2023","unstructured":"McAuley, G. E. et al. Human T cell generation is restored in CD3\u03b4 severe combined immunodeficiency through adenine base editing. Cell 186, 1398\u20131416.e23 (2023).","journal-title":"Cell"},{"key":"1651_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg6518","volume":"380","author":"M Arbab","year":"2023","unstructured":"Arbab, M. et al. Base editing rescue of spinal muscular atrophy in cells and in mice. Science 380, eadg6518 (2023).","journal-title":"Science"},{"key":"1651_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41551-023-01132-z","volume":"8","author":"CRR Alves","year":"2024","unstructured":"Alves, C. R. R. et al. Optimization of base editors for the functional correction of SMN2 as a treatment for spinal muscular atrophy. Nat. Biomed. Eng. 8, 118\u2013131 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"1651_CR36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ymgme.2014.01.008","volume":"111","author":"S Hiebler","year":"2014","unstructured":"Hiebler, S. et al. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder. Mol. Genet. Metab. 111, 522\u2013532 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"1651_CR37","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1016\/j.bbadis.2019.06.013","volume":"1865","author":"K Berendse","year":"2019","unstructured":"Berendse, K. et al. Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2774\u20132787 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1651_CR38","doi-asserted-by":"publisher","first-page":"107713","DOI":"10.1016\/j.exer.2019.107713","volume":"186","author":"C Argyriou","year":"2019","unstructured":"Argyriou, C. et al. A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild Zellweger spectrum disorder. Exp. Eye Res. 186, 107713 (2019).","journal-title":"Exp. Eye Res."},{"key":"1651_CR39","doi-asserted-by":"crossref","unstructured":"Demaret, T. et al. Longitudinal study of Pex1-G844D NMRI mouse model: a robust pre-clinical model for mild Zellweger spectrum disorder. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165900 (2020).","DOI":"10.1016\/j.bbadis.2020.165900"},{"key":"1651_CR40","doi-asserted-by":"crossref","unstructured":"Demaret, T. et al. High dose versus low dose syngeneic hepatocyte transplantation in Pex1-G844D NMRI mouse model is safe but does not achieve long term engraftment. Cells 10, 40 (2020).","DOI":"10.3390\/cells10010040"},{"key":"1651_CR41","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1651_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551, 464 (2017).","journal-title":"Nature"},{"key":"1651_CR43","first-page":"1","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 1\u20139 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1651_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535\u2013548.e24 (2019).","journal-title":"Cell"},{"key":"1651_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).","journal-title":"Science"},{"key":"1651_CR46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"1651_CR47","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1651_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1651_CR49","doi-asserted-by":"crossref","unstructured":"Argyriou, C. et al. AAV-mediated PEX1 gene augmentation improves visual function in the PEX1-Gly844Asp mouse model for mild Zellweger spectrum disorder. Mol. Ther. Methods Clin. Dev. 23, 225\u2013240 (2021).","DOI":"10.1016\/j.omtm.2021.09.002"},{"key":"1651_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2017.07.001","volume":"73","author":"F Braet","year":"2018","unstructured":"Braet, F., Taatjes, D. J. & Wisse, E. Probing the unseen structure and function of liver cells through atomic force microscopy. Semin. Cell Dev. Biol. 73, 13\u201330 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1651_CR51","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.omtm.2020.10.011","volume":"19","author":"SN Mathiesen","year":"2020","unstructured":"Mathiesen, S. N., Lock, J. L., Schoderboeck, L., Abraham, W. C. & Hughes, S. M. CNS transduction benefits of AAV-PHP.eB over AAV9 are dependent on administration route and mouse strain. Mol. Ther. Methods Clin. Dev. 19, 447\u2013458 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1651_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00018-023-04827-3","volume":"80","author":"L Chi","year":"2023","unstructured":"Chi, L. et al. Loss of functional peroxisomes leads to increased mitochondrial biogenesis and reduced autophagy that preserve mitochondrial function. Cell. Mol. Life Sci. 80, 183 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"1651_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006825","volume":"13","author":"MF Wangler","year":"2017","unstructured":"Wangler, M. F. et al. Peroxisomal biogenesis is genetically and biochemically linked to carbohydrate metabolism in Drosophila and mouse. PLoS Genet. 13, e1006825 (2017).","journal-title":"PLoS Genet."},{"key":"1651_CR54","doi-asserted-by":"crossref","unstructured":"Miura, Y. The biological significance of \u03c9-oxidation of fatty acids. Proc. Jpn Acad. Ser. B 89, 370 (2013).","DOI":"10.2183\/pjab.89.370"},{"key":"1651_CR55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2013.08.032","volume":"5","author":"J Ding","year":"2013","unstructured":"Ding, J. et al. The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids. Cell Rep. 5, 248\u2013258 (2013).","journal-title":"Cell Rep."},{"key":"1651_CR56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3390\/ijms23020987","volume":"23","author":"Y Khalil","year":"2022","unstructured":"Khalil, Y. et al. Tissue proteome of 2-hydroxyacyl-CoA lyase deficient mice reveals peroxisome proliferation and activation of \u03c9-oxidation. Int. J. Mol. Sci. 23, 987 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1651_CR57","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"1651_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ehjcvp\/pvad103","volume":"10","author":"T Horie","year":"2023","unstructured":"Horie, T. & Ono, K. VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients. Eur. Heart J. Cardiovasc. Pharmacother. 10, 89\u201390 (2023).","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"1651_CR59","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S. & Liu, D. R. Therapeutic in vivo delivery of gene editing agents. Cell 185, 2806\u20132827 (2022).","journal-title":"Cell"},{"key":"1651_CR60","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","volume":"29","author":"GA Newby","year":"2021","unstructured":"Newby, G. A. & Liu, D. R. In vivo somatic cell base editing and prime editing. Mol. Ther. 29, 3107\u20133124 (2021).","journal-title":"Mol. Ther."},{"key":"1651_CR61","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/adma.201505822","volume":"28","author":"OS Fenton","year":"2016","unstructured":"Fenton, O. S. et al. Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery. Adv. Mater. 28, 2939\u20132943 (2016).","journal-title":"Adv. Mater."},{"key":"1651_CR62","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nmeth.4278","volume":"14","author":"SQ Tsai","year":"2017","unstructured":"Tsai, S. Q. et al. CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR\u2013Cas9 nuclease off-targets. Nat. Methods 14, 607\u2013614 (2017).","journal-title":"Nat. Methods"},{"key":"1651_CR63","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1651_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41592-018-0006-2","volume":"15","author":"XD Gao","year":"2018","unstructured":"Gao, X. D. et al. C-BERST: defining subnuclear proteomic landscapes at genomic elements with dCas9\u2013APEX2. Nat. Methods 15, 1\u20134 (2018).","journal-title":"Nat. Methods"},{"key":"1651_CR65","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00418-020-01855-z","volume":"153","author":"T Demaret","year":"2020","unstructured":"Demaret, T. et al. Accurate and live peroxisome biogenesis evaluation achieved by lentiviral expression of a green fluorescent protein fused to a peroxisome targeting signal 1. Histochem. Cell Biol. 153, 295\u2013306 (2020).","journal-title":"Histochem. Cell Biol."},{"key":"1651_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1083\/jcb.136.1.71","volume":"136","author":"EAC Wiemer","year":"1997","unstructured":"Wiemer, E. A. C., Wenzel, T., Deerinck, T. J., Ellisman, M. H. & Subramani, S. Visualization of the peroxisomal compartment in living mammalian cells: dynamic behavior and association with microtubules. J. Cell Biol. 136, 71\u201380 (1997).","journal-title":"J. Cell Biol."},{"key":"1651_CR67","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nbt1095","volume":"23","author":"TA Kost","year":"2005","unstructured":"Kost, T. A., Condreay, J. P. & Jarvis, D. L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23, 567\u2013575 (2005).","journal-title":"Nat. Biotechnol."},{"key":"1651_CR68","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","volume":"6","author":"JR Davis","year":"2022","unstructured":"Davis, J. R. et al. Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors. Nat. Biomed. Eng. 6, 1272\u20131283 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1651_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/genbio.2022.0015","volume":"1","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. Adenine base editing in vivo with a single adeno-associated virus vector. GEN Biotechnol. 1, 285\u2013299 (2022).","journal-title":"GEN Biotechnol."},{"key":"1651_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-61779-370-7_6","volume":"807","author":"MS Sands","year":"2011","unstructured":"Sands, M. S. Adeno-associated virus, methods and protocols. Methods Mol. Biol. 807, 141\u2013157 (2011).","journal-title":"Methods Mol. Biol."},{"key":"1651_CR71","doi-asserted-by":"publisher","first-page":"118569","DOI":"10.1016\/j.atherosclerosis.2024.118569","volume":"398","author":"P Prabutzki","year":"2024","unstructured":"Prabutzki, P., Schiller, J. & Engel, K. M. Phospholipid-derived lysophospholipids in (patho)physiology. Atherosclerosis 398, 118569 (2024).","journal-title":"Atherosclerosis"},{"key":"1651_CR72","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/ijms20051149","volume":"20","author":"S-H Law","year":"2019","unstructured":"Law, S.-H. et al. An updated review of lysophosphatidylcholine metabolism in human diseases. Int. J. Mol. Sci. 20, 1149 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1651_CR73","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1194\/jlr.D011916","volume":"52","author":"CJ Pynn","year":"2011","unstructured":"Pynn, C. J. et al. Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo [S]. J. Lipid Res. 52, 399\u2013407 (2011).","journal-title":"J. Lipid Res."},{"key":"1651_CR74","doi-asserted-by":"publisher","first-page":"37798","DOI":"10.1074\/jbc.M508575200","volume":"280","author":"Z Li","year":"2005","unstructured":"Li, Z., Agellon, L. B. & Vance, D. E. Phosphatidylcholine homeostasis and liver failure. J. Biol. Chem. 280, 37798\u201337802 (2005).","journal-title":"J. Biol. Chem."},{"key":"1651_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s43856-024-00605-9","volume":"4","author":"YRJ Jaspers","year":"2024","unstructured":"Jaspers, Y. R. J. et al. Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy. Commun. Med. 4, 175 (2024).","journal-title":"Commun. Med."},{"key":"1651_CR76","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbalip.2014.12.005","volume":"1851","author":"MJA Schackmann","year":"2015","unstructured":"Schackmann, M. J. A., Ofman, R., Dijkstra, I. M. E., Wanders, R. J. A. & Kemp, S. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1851, 231\u2013237 (2015).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"1651_CR77","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s40001-023-01523-7","volume":"28","author":"X Wang","year":"2023","unstructured":"Wang, X., Yu, H., Gao, R., Liu, M. & Xie, W. A comprehensive review of the family of very-long-chain fatty acid elongases: structure, function, and implications in physiology and pathology. Eur. J. Med. Res. 28, 532 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"1651_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6793-10-19","volume":"10","author":"PA Watkins","year":"2010","unstructured":"Watkins, P. A. et al. Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions. BMC Physiol. 10, 19 (2010).","journal-title":"BMC Physiol."},{"key":"1651_CR79","unstructured":"Waterham, H. R., Wanders, R. J. & Leroy, B. P. in GeneReviews (eds Adam, M. P. et al.) (Univ. Washington, 2021)."},{"key":"1651_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","volume":"18","author":"SC Kim","year":"2022","unstructured":"Kim, S. C. et al. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Mol. Cell. Toxicol. 18, 1\u20138 (2022).","journal-title":"Mol. Cell. Toxicol."},{"key":"1651_CR81","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"1651_CR82","doi-asserted-by":"publisher","first-page":"857276","DOI":"10.3389\/fimmu.2022.857276","volume":"13","author":"D-A Gross","year":"2022","unstructured":"Gross, D.-A., Tedesco, N., Leborgne, C. & Ronzitti, G. Overcoming the challenges imposed by humoral immunity to AAV vectors to achieve safe and efficient gene transfer in seropositive patients. Front. Immunol. 13, 857276 (2022).","journal-title":"Front. Immunol."},{"key":"1651_CR83","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"1651_CR84","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265.e16 (2022).","journal-title":"Cell"},{"key":"1651_CR85","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526\u20131537 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1651_CR86","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","volume":"17","author":"JL Doman","year":"2022","unstructured":"Doman, J. L., Sousa, A. A., Randolph, P. B., Chen, P. J. & Liu, D. R. Designing and executing prime editing experiments in mammalian cells. Nat. Protoc. 17, 2431\u20132468 (2022).","journal-title":"Nat. Protoc."},{"key":"1651_CR87","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/jobm.202100008","volume":"61","author":"X He","year":"2021","unstructured":"He, X. et al. Optimized protocol for high-titer lentivirus production and transduction of primary fibroblasts. J. Basic Microbiol. 61, 430\u2013442 (2021).","journal-title":"J. Basic Microbiol."},{"key":"1651_CR88","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"1651_CR89","doi-asserted-by":"publisher","first-page":"W415","DOI":"10.1093\/nar\/gkae456","volume":"52","author":"JM Elizarraras","year":"2024","unstructured":"Elizarraras, J. M. et al. WebGestalt 2024: faster gene set analysis and new support for metabolomics and multi-omics. Nucleic Acids Res. 52, W415\u2013W421 (2024).","journal-title":"Nucleic Acids Res."},{"key":"1651_CR90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10\u201312 (2011).","journal-title":"EMBnet J."},{"key":"1651_CR91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0009-8981(90)90077-6","volume":"192","author":"F Stellaard","year":"1990","unstructured":"Stellaard, F., ten Brink, H. J., Kok, R. M., Heuvel, L. V. D. & Jakobs, C. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography. Clin. Chim. Acta 192, 133\u2013144 (1990).","journal-title":"Clin. Chim. Acta"},{"key":"1651_CR92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0022-2275(20)41881-4","volume":"33","author":"HJ Brink","year":"1992","unstructured":"Brink, H. J. et al. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography. J. Lipid Res. 33, 41\u201347 (1992).","journal-title":"J. Lipid Res."},{"key":"1651_CR93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/mgme.2001.3170","volume":"73","author":"SA Lagerstedt","year":"2001","unstructured":"Lagerstedt, S. A. et al. Quantitative determination of plasma C8\u2013C26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol. Genet. Metab. 73, 38\u201345 (2001).","journal-title":"Mol. Genet. Metab."},{"key":"1651_CR94","doi-asserted-by":"publisher","first-page":"361590","DOI":"10.1155\/2014\/361590","volume":"2014","author":"SC Taylor","year":"2014","unstructured":"Taylor, S. C. & Posch, A. The design of a quantitative western blot experiment. BioMed Res. Int. 2014, 361590 (2014).","journal-title":"BioMed Res. Int."},{"key":"1651_CR95","doi-asserted-by":"publisher","first-page":"29692","DOI":"10.1074\/jbc.E115.000002","volume":"290","author":"AJ Fosang","year":"2015","unstructured":"Fosang, A. J. & Colbran, R. J. Transparency is the key to quality. J. Biol. Chem. 290, 29692\u201329694 (2015).","journal-title":"J. Biol. Chem."},{"key":"1651_CR96","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1038\/s41596-018-0055-0","volume":"13","author":"CR Lazzarotto","year":"2018","unstructured":"Lazzarotto, C. R. et al. Defining CRISPR\u2013Cas9 genome-wide nuclease activities with CIRCLE-seq. Nat. Protoc. 13, 2615\u20132642 (2018).","journal-title":"Nat. Protoc."},{"key":"1651_CR97","doi-asserted-by":"publisher","unstructured":"Gao, X. D. et al. Raw and unprocessed microscope images for Fig. 6 and Ext. Data Fig. 10. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.31129660 (2026).","DOI":"10.6084\/m9.figshare.31129660"},{"key":"1651_CR98","unstructured":"Gao, X. D. et al. Cellprofiler script. Figshare https:\/\/figshare.com\/s\/9eda20bcd55d6ce3511c (2025)."},{"key":"1651_CR99","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01651-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01651-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01651-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:02:37Z","timestamp":1776157357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01651-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":99,"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01651-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.D.G., M.P., J.G.H., C.M.L. and D.R.L. have filed patent applications on this work. D.R.L. is a consultant and\/or equity owner of Prime Medicine, Beam Therapeutics, Pairwise Plants, Exo Therapeutics and nChroma Bio, companies that use or deliver genome editing or epigenome-modulating agents. J.M.L. is a current employee of Prime Medicine. X.D.G. is currently an assistant professor at the University of Pittsburgh School of Medicine, S.B. is currently an assistant professor at Boston University, and G.A.N. is currently an assistant professor at the Johns Hopkins University. B.H.S. is a current employee of Genvivo, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}